BioNano Genomics, Inc. Aktie News
0,95 $
0,07 %
Nasdaq,
3. Mai, 22:13 Uhr
tracken
BioNano Genomics, Inc. Aktie News
Positiv
InvestorPlace
●
11 Tage alt
Many investors abandon highly promising shares with little chance of failing. The phenomenon has been exacerbated by overdone fears about elevated interest rates.
Neutral
GlobeNewsWire
●
25 Tage alt
Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural variants.
Neutral
GlobeNewsWire
●
etwa ein Monat alt
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 8,733,626 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 8,733,626 shares of its common stock at an offering price of $1.145 per sha...
Neutral
GlobeNewsWire
●
etwa ein Monat alt
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to classical cytogenetic techniques used for analysis of solid tumor cancer samples consisting of soft tissue and bone sarcomas, including fluorescence in situ hybridization (FISH) and karyotyping (KT). OGM demon...
Neutral
GlobeNewsWire
●
etwa 2 Monate alt
SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting 2024 with a broad range of content covering optical genome mapping's (OGM) utility for research areas including cancer, rare genetic disease and constitutional disorders. ACMG's Annu...
Neutral
Seeking Alpha
●
2 Monate alt
Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript
Neutral
GlobeNewsWire
●
2 Monate alt
SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2023 and revenue outlook for 2024.
Neutral
GlobeNewsWire
●
2 Monate alt
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at TD Cowen's 44th Annual Health Care Conference on March 6, 2024.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
